Austrian BioImaging Industry Board (ABIB) Kick-off Meeting

BioImaging Austria/CMI (Correlated Multimodal Imaging Node Austria) has established an Industry Board to connect all stakeholders interested in bioimaging and image processing in Austria. Concerted efforts and activities among life scientists, imaging scientists, computer experts, and the industry will foster multimodal imaging and drive innovation.

All participating companies signed the Membership Agreement during the Kick-off Meeting - with more companies expressing their interest. Bodo Falke from Leica and Alain Pitiot from Ilixa got elected President and Vice-President of the ABIB. ABIB consists of the following companies and startups:

  • Carl Zeiss GmbH
  • Contextflow GmbH
  • Leica Mikrosysteme
  • Ilixa GmbH
  • ImageBiopsy Lab GmbH
  • Nexperion e.U.
  • NGFI GmbH
  • Nikon CEE GmbH
  • OLYMPUS Austria GmbH
  • piur imaging GmbH
  • Thermo Fisher Scientific - Amira
  • Thermo Fisher Scientific – FEI Deutschland GmbH
  • TissueGnostics GmbH
  • SCARLETRED Holding GmbH

About CMI
The Correlated Multimodal Imaging Node Austria (CMI) is a professional consortium of multiple Austrian Science Institutions and the official Austrian BioImaging initiative. It is coordinated by the Medical University of Vienna (MedUni) and the Vienna Biocenter Core Facilities GmbH (VBCF). CMI is currently operated as an independent entity, but aims at becoming an integrative part of the Euro-BioImaging project.


Andreas Walter
Operating Director BioImaging Austria (CMI)
+43 179 62324 7040

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)